Plasmapp (CEO Lim Yu-bong) recently announced that it signed a Japanese sales agency contract with Nextera (CEO Nishikawa Atsushi).

With this agreement, Plasmapp plans to accelerate sales of regenerative activators in the Japanese market through the new product ‘ACTILINK Reborn’.

The two companies signed a contract for a total of 2,500 units (500 units per year) over 5 years, and are continuing smooth sales with 100 units delivered last month.

‘ACTILINK Reborn’ uses biological regeneration and activation technology using plasma to remove hydrocarbons and impurities on the surface of implants generated during the implant distribution process. Through this, the hydrophilicity and protein adsorption of the implant can be improved, and the stabilization period of surgery can be significantly shortened due to excellent biocompatibility. Plasmapp explains that the implant can be regenerated and activated by removing hydrocarbons and impurities that are attached and generated on the implant surface through plasma treatment within one minute before surgery.

An official from Nextera said, “By selling Plasmapp’s proven products, we have expanded the base of the Japanese dental market and created an opportunity for both companies to grow together by leading a virtuous cycle in the implant market.” He added, “We will continue to expand Plasmapp technology through continued cooperation in the future.” “I will spread the word about it,” he said.

Source: Dental News ( http://www.dentalnews.or.kr )